Do Concord Biotech's (NSE:CONCORDBIO) Earnings Warrant Your Attention? - simplywall.st
2025-04-08 • Google News
Concord Biotech Limited (CONCORDBIO)
NSEINR 17931.83%
Price Chart
Key Statistics
Market Cap
INR 186.64B
P/E Ratio
50.27
Revenue (TTM)
INR 12B
Volume
298.43K
52W High
INR 2664.00
52W Low
INR 1345.00
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
1718.182
200-Day MA
1875.5345
52 Week High
2664
52 Week Low
1345
About CONCORDBIO
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. The company provides .
Employees
N/A
Headquarters
Ahmedabad, India
CEO
Mr. Sudhir Jairam Vaid
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg